Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sublingual Administration of a Polyvalent Mechanical Bacterial Lysate in Patients With Moderate, Severe or Very Severe COPD According to GOLD Classification: a Multicenter, Double Blind, Randomized, Controlled, Phase IV Study

NCT02417649 is registered in ClinicalTrials.gov with Lallemand Pharma AG as lead sponsor.

NCT NCT02417649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02417649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sublingual Administration of a Polyvalent Mechanical Bacterial Lysate in Patients With Moderate, Severe or Very Severe COPD According to GOLD Classification: a Multicenter, Double Blind, Randomized, Controlled, Phase IV Study
Lead sponsor
Lallemand Pharma AG
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2009
Completion date
July 31, 2013
Enrollment
288 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)